Tiger Brokers

Boan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026

Bulletin Express
May 07

Shandong Boan Biotechnology Co., Ltd. reported no changes in its share capital structure for the month ended 30 April 2026. Authorised/registered and issued H-shares both closed the month unchanged at 622.33 million shares with a par value of RMB 1.00 each, keeping total registered capital at RMB 622.33 million.

The company held no treasury shares during the period, and no share options, warrants, convertibles or other equity instruments were outstanding or exercised.

Directors confirmed that the public float remained above the minimum 18.14 percent threshold specified under the Stock Exchange waiver—satisfying Main Board Rule 13.32D(1).

All statutory confirmations were filed by Director Jiang Hua on 07 May 2026, stating full compliance with Hong Kong Listing Rules and other regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10